Nicolas Vallée Selected Research

Decompression Sickness (Bends)

1/2019	Demonstration by Infra-Red Imaging of a Temperature Control Defect in a Decompression Sickness Model Testing Minocycline.
1/2018	Reduction in the Level of Plasma Mitochondrial DNA in Human Diving, Followed by an Increase in the Event of an Accident.
1/2018	Tirofiban, a Glycoprotein IIb/IIIa Antagonist, Has a Protective Effect on Decompression Sickness in Rats: Is the Crosstalk Between Platelet and Leukocytes Essential?
1/2017	Thirty-five Day Fluoxetine Treatment Limits Sensory-Motor Deficit and Biochemical Disorders in a Rat Model of Decompression Sickness.
1/2016	Fluoxetine Protection in Decompression Sickness in Mice is Enhanced by Blocking TREK-1 Potassium Channel with the "spadin" Antidepressant.
12/2015	Fluoxetine stimulates anti-inflammatory IL-10 cytokine production and attenuates sensory deficits in a rat model of decompression sickness.
10/2015	Xenon Blocks Neuronal Injury Associated with Decompression.
1/2013	Submarine rescue decompression procedure from hyperbaric exposures up to 6 bar of absolute pressure in man: effects on bubble formation and pulmonary function.
1/2013	Sidenafil pre-treatment promotes decompression sickness in rats.
6/2012	Oxygen breathing or recompression during decompression from nitrox dives with a rebreather: effects on intravascular bubble burden and ramifications for decompression profiles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicolas Vallée Research Topics

Disease

10	Decompression Sickness (Bends) 01/2019 - 06/2012
4	Brain Ischemia (Cerebral Ischemia) 07/2016 - 12/2015
3	Ischemic Stroke 07/2017 - 01/2016
3	Inert Gas Narcosis (Nitrogen Narcosis) 07/2011 - 02/2009
2	Wounds and Injuries (Trauma) 01/2018 - 01/2013
2	Ischemia 07/2016 - 01/2016
2	High Pressure Neurological Syndrome (High Pressure Nervous Syndrome) 04/2016 - 02/2009
1	Hyperoxia 01/2020
1	Infarction (Infarctions) 07/2016
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2016
1	Edema (Dropsy) 04/2016
1	Hypothermia 01/2016
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2016
1	Stroke (Strokes) 01/2016
1	Air Embolism (Gas Embolism) 01/2013
1	Stupor 05/2009
1	Epilepsy (Aura) 02/2009

Drug/Important Bio-Agent (IBA)

8	Oxygen (Dioxygen)IBA 07/2017 - 05/2009
3	Fluoxetine (Prozac)FDA LinkGeneric 01/2017 - 12/2015
3	Tissue Plasminogen Activator (Alteplase)FDA Link 07/2016 - 01/2016
3	HeliumIBA 01/2016 - 02/2009
2	Glucose (Dextrose)FDA LinkGeneric 07/2017 - 07/2016
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2017 - 07/2016
2	Antidepressive Agents (Antidepressants)IBA 01/2016 - 12/2015
2	Dopamine (Intropin)FDA LinkGeneric 07/2011 - 05/2009
2	Glutamic Acid (Glutamate)FDA Link 07/2011 - 05/2009
2	NitrogenIBA 05/2009 - 02/2009
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020
1	Minocycline (Cyclops)FDA LinkGeneric 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Tirofiban (Aggrastat)FDA Link 01/2018
1	Mitochondrial DNA (mtDNA)IBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	Narcotics (Narcotic Analgesics)IBA 04/2016
1	Neuroprotective AgentsIBA 01/2016
1	potassium channel protein TREK-1IBA 01/2016
1	ArgonIBA 01/2016
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2016
1	Noble Gases (Rare Gases)IBA 01/2016
1	XenonIBA 01/2016
1	Interleukin-10 (Interleukin 10)IBA 12/2015
1	CytokinesIBA 12/2015
1	nitroxIBA 06/2012
1	CitrullineIBA 07/2011
1	Amino Acids FDA Link 05/2009

Therapy/Procedure

3	Decompression 01/2013 - 06/2012
1	Therapeutics 01/2016